Y., M., P., S., T., A., A., M. (2022). INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY. test, 5(2), 145-149. doi: 10.21608/ejco.2022.280977
Mostafa, Y.; Sameh, P.; Altak, T.; Marrie, A.. "INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY". test, 5, 2, 2022, 145-149. doi: 10.21608/ejco.2022.280977
Y., M., P., S., T., A., A., M. (2022). 'INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY', test, 5(2), pp. 145-149. doi: 10.21608/ejco.2022.280977
Y., M., P., S., T., A., A., M. INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY. test, 2022; 5(2): 145-149. doi: 10.21608/ejco.2022.280977

INCIDENCE OF ENDOPHTHALMITIS AFTER INTRA-OPERATIVE MOXIFLOXACIN INJECTION IN THE CAPSULAR BAG, BEHIND THE INTRA OCULAR LENS, IN PHACOEMULSIFICATION. A RETROSPECTIVE STUDY

Egyptian Journal of Clinical Ophthalmology
Article 10, Volume 5, Issue 2, December 2022, Pages 145-149    PDF (278.19 K)
Document Type: Original articles: include clinical trials, interventional research, Basic researches and clinically relevant laboratory investigations
DOI: 10.21608/ejco.2022.280977
Authors
Mostafa, Y.1; Sameh, P.2; Altak, T.3; Marrie, A.1
1Ophthalmology dept., Faculty of Medicine, Cairo, Univ., Egypt
2Ophthalmology dept., Faculty of Medicine, Cairo, Univ., Egypt,
3Sheikh Khalifa Medical City - Ajman (SKMCA), UAE
Abstract
Purpose: to evaluate the efficacy and safety of intracapsular moxifloxacin injection at the end
of phacoemulsification as a prophylactic measure against early and late endophthalmitis.
Setting: private eye center, eye Care, Cairo, Egypt. Methods: This is a retrospective clinical
registry-based study. Data was collected from patients who had phacoemulsification within
the capsular bag injection of moxifloxacin at the end of surgery. 0.2 ml of moxifloxacin 0.5%
ophthalmic solution was injected into the bag by placing the tip of the cannula under the
capsulorhexis edge and directing the drug behind the IOL. Results: Data were collected from
EMR for 10919 eyes, that underwent phacoemulsification and in the bag moxifloxacin injection
between January 2015 and August 2022, 4 cases of early endophthalmitis were reported with an
incidence of 0.03%, no cases of late-endophthalmitis, and no cases of toxicity. Conclusion:
Intracapsular moxifloxacin injection at the end of phacoemulsification is a safe effective
prophylactic measure against endophthalmitis.

Keywords
Endophthalmitis; Moxifloxacin; Phacoemulsification
Statistics
Article View: 102
PDF Download: 312